When news outlets also publish so-called ‘native advertising,’ their journalistic reputations suffer – and their news coverage shies away from the companies that paid for the ads.
Academic rigour, journalistic flair
Articles on Philip Morris
Displaying 1 - 20 of 21 articles
Ultra-processed foods meet the same criteria for addictiveness that tobacco products do – and they’ve even been marketed in similar ways.
Tobacco giant Philip Morris has acquired British company Vectura, which make puffers and nebulisers that help people with lung disease to breathe.
New research published in Long Range Planning provides insights on how a spin-off’s status and attachment to its former parent influence its risk-taking.
Australia has won a decisive victory against tobacco interests using trade deals to challenge plain packaging laws. But don’t expect that to deter similar threats against other nations.
As vaping-related illnesses increase and deaths reported, an inhalation toxicologist explains why comparing the dangers of vaping to the dangers from cigarettes doesn’t make sense.
The history of Paraguay’s role in the global illicit tobacco trade, and its implications.
How industry-funded data on tobacco smuggling exaggerates the scale of the problem.
While many of its Asian neighbours are striving to get smoking under control, Indonesia is the stubborn exception.
On World No Tobacco Day, the focus is usually on the health risks of cigarettes. But what about the way Big Tobacco exploits impoverished farmers in Malawi?
Philip Morris has applied to the FDA to market a product that it says is safer than a cigarette, but its own data show that is not true.
FDA Director Scott Gottlieb has proposed discussions about drastically cutting nicotine levels in cigarettes. This could result in some of the biggest health gains in history.
Thanks to voters ignoring Big Tobacco, California may be the first smoke free society. Here’s how it happened.
California, the nation’s single largest market for cigarettes, has one of the lowest taxes on them. A proposal to raise the tax by US$2 a pack could signal a sea change.
The Uruguayan government’s victory over Philip Morris should embolden other countries to introduce stronger tobacco-control policies.
Surely, no bookmaker will take bets on what the principal recommendation of Leyonhjelm’s wasteful exercise will be: that tobacco tax should fall.
Australia’s plain packaging win over Philip Morris will kill the ISDS bogeyman.
The experience of Canada, which agreed to an ISDS clause in its North American Free Trade agreement, should give pause to Australia.
Cancer Council Victoria is contesting British American Tobacco’s request for survey data about teenagers’ smoking habits. Here’s the story of a UK research group who faced a similar request.
Restricting entities such as tobacco companies’ use of FOI laws is not the best legal response if it helps public bodies generally become more secretive.
Job Board
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
-
Technical Skills Laboratory Officer
-
Faculty of Law - Academic Appointment Opportunities
-
Audience Development Coordinator (fixed-term maternity cover)
Top contributors
-
Professor of Medicine, University of California, San Francisco
-
Emeritus Professor in Public Health, University of Sydney
-
Associate Research Professor, University of South Australia
-
Professor of Public Health/Director, Tobacco Control Research Group, University of Bath
-
Professor at the Institute for Social Marketing, University of Stirling
-
Reader in Intellectual Property Law, City, University of London
-
Associate Professor, Faculty of Law, University of Technology Sydney
-
Professor and Dean, School of Public Health, Georgia State University
-
Lecturer in Law, Curtin University
-
Lecturer in Intellectual Property and Human Rights, University of Technology Sydney
-
Assistant Professor, Faculty of Health Sciences, Simon Fraser University
-
Lecturer in Marketing, Edinburgh Napier University
-
Postdoctoral Research Fellow, Department of Health, University of Bath
-
Sessional Lecturer, Munk School of Global Affairs and Public Policy, University of Toronto
-
Senior Research Fellow/Professor, ESCP Business School
